PharMerica announces expiration of HSR Waiting Period to acquire Chem Rx

PharMerica Corporation (NYSE: PMC), a national provider of institutional pharmacy and hospital pharmacy management services, announced today that the waiting period under the Hart-Scott-Rodino Act (the HSR Waiting Period) applicable to the bid to acquire substantially all of the assets of Chem Rx Corporation has expired. The HSR Waiting Period expired without a request for additional information from the federal antitrust authorities.

The proposed transaction, previously announced on September 27, 2010, remains subject to approval by the Bankruptcy Court, the satisfaction of the conditions set forth in the purchase agreement and other regulatory approvals.